November 6, 2017 — Three-year data from the FAME 2 study show patients with coronary artery disease who underwent a...
TCT
This channel contains news about the annual Transcatheter Cardiovascular Therapeutics (TCT) conference presented by the Cardiovascular Research Foundation (CRF). It includes coverage from the annual meeting and links CRF news. TCT is the premier conference for the subspecialty of interventional cardiology, including the new subspecialty areas of transcatheter structural heart procedures.
FAME2 cost effectiveness of FFR guided PCI vs. medical therapy alone.
News | FFR Technologies | November 06, 2017
Technology | FFR Technologies | November 03, 2017
November 3, 2017 — Acist Medical Systems Inc., a Bracco Group Company, announced the global launch of its Acist RXi...
Feature | Atrial Fibrillation | November 02, 2017
November 2, 2017 – Five-year results from the PREVAIL Trial comparing left atrial appendage closure (LAAC) with the...
An illustration of the Sequent Please drug-coated balloon.
Feature | Drug-Eluting Balloons | November 02, 2017
November 2, 2017 — The treatment of in-stent restenosis (ISR) remains challenging in clinical practice. The DARE (...
News | Chronic Total Occlusion (CTO) | November 02, 2017
November 2, 2017 — Crossing the occlusion with a guidewire is often the most challenging part of...
Image courtesy of OrbusNeich
News | Stents Drug Eluting | November 01, 2017
November 1, 2017 — OrbusNeich reported results from the REDUCE trial in the Late-Breaking Clinical Trial session at...
News | Stents Bifurcation | November 01, 2017
November 1, 2017 — The double kissing (DK) crush two-stent technique was associated with a lower rate of target...
News | Cardiac Diagnostics | November 01, 2017
November 1, 2017 — Analytics 4 Life announced it will be presenting new clinical data on the company's ongoing...
News | Heart Valve Technology | November 01, 2017
November 1, 2017 — Analysis of the PARTNER 2A trial and the SAPIEN-3 Intermediate Risk registry found...
News | Cath Lab | November 01, 2017
Culprit Lesion-Only PCI Improves Outcomes for Cardiogenic Shock Patients Compared to Multivessel PCI
November 1, 2017 — Results from the prospective, randomized, multicenter CULPRIT-SHOCK trial found an initial...
The Boston Scientific FilterWire EZ embolic protection system.
News | Embolic Protection Devices | October 31, 2017
October 31, 2017 — The VAMPIRE 3 study evaluated if the selective use of distal filter protection might decrease the...
News | Heart Valve Technology | October 31, 2017
October 31, 2017 — Edwards Lifesciences Corp. announced new data demonstrating substantial economic advantages of...
News | Stents Bioresorbable | October 31, 2017
October 31, 2017 – Thirty-day results from ABSORB IV, the largest randomized everolimus-eluting...
